{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:33Z","timestamp":1761100713541,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3965,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.bbmt.2004.02.004","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T10:10:05Z","timestamp":1085825405000},"page":"415-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support"],"prefix":"10.1016","volume":"10","author":[{"given":"Yago","family":"Nieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbur A","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy B","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott I","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Pellom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna E","family":"Bar\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J","family":"Shpall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2004.02.004_BIB1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00001622-200403000-00005","article-title":"High-dose chemotherapy for breast cancer","volume":"16","author":"Nieto","year":"2004","journal-title":"Curr Opin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB2","first-page":"CD003142","article-title":"High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer","author":"Farquhar","year":"2003","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB3","first-page":"CD003139","article-title":"High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer","author":"Farquhar","year":"2003","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01807031","article-title":"Immunocytochemical detection of breast cancer cells in bone marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support","volume":"41","author":"Franklin","year":"1996","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1200\/JCO.1994.12.3.475","article-title":"Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction","volume":"12","author":"Datta","year":"1994","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0959-8049(97)00014-2","article-title":"The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19","volume":"33","author":"Schoenfeld","year":"1997","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB7","doi-asserted-by":"crossref","first-page":"8672","DOI":"10.1073\/pnas.84.23.8672","article-title":"Micrometastatic cancer cells in bone marrow","volume":"84","author":"Schlimok","year":"1987","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB8","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.1997.15.7.2701","article-title":"Limitations of reverse-transcriptase polymerase-chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow","volume":"15","author":"Zippelius","year":"1997","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB9","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/88.22.1652","article-title":"Micrometastatic breast cancer cells in bone marrow at primary surgery","volume":"88","author":"Diel","year":"1996","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM200002243420801","article-title":"Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer","volume":"342","author":"Braun","year":"2000","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(98)10175-7","article-title":"Outcome of primary-breast-cancer patients with micrometastases","volume":"354","author":"Mansi","year":"1999","journal-title":"Lancet."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1200\/JCO.2001.19.5.1468","article-title":"Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy","volume":"19","author":"Braun","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB13","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1200\/JCO.2001.19.16.3669","article-title":"Epithelial cells in bone marrow of breast cancer patients at time of primary surgery","volume":"19","author":"Gebauer","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB14","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1200\/JCO.2001.19.4.960","article-title":"Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors","volume":"19","author":"Gerber","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB15","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1200\/JCO.1991.9.10.1749","article-title":"Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases","volume":"9","author":"Cote","year":"1991","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1005980919916","article-title":"Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis","volume":"49","author":"Landys","year":"1998","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB17","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1200\/JCO.2003.02.009","article-title":"Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer","volume":"21","author":"Wiedswang","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB18","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1200\/JCO.1996.14.6.1868","article-title":"Clinical significance of bone marrow metastases in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation","volume":"14","author":"Fields","year":"1996","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB19","first-page":"91","article-title":"The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support","volume":"3","author":"Vredenburgh","year":"1997","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB20","first-page":"79a","article-title":"The prognostic value of bone marrow micrometastases in stage II\/III breast cancer patients undergoing autologous transplant (ABMT) therapy","volume":"17","author":"Umiel","year":"1998","journal-title":"Proc Am Soc Clin Oncol."},{"issue":"suppl 10","key":"10.1016\/j.bbmt.2004.02.004_BIB21","first-page":"128A","article-title":"The prognostic value of immunocytochemical (ICC) analysis on bone marrow (BM) taken from patients with stage IV breast cancer undergoing autologous transplant (ABMT) therapy","volume":"88","author":"Moss","year":"1996","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB22","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood.V82.9.2605.2605","article-title":"Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques","volume":"82","author":"Ross","year":"1993","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.bmt.1700817","article-title":"Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients","volume":"19","author":"Schulze","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bmt.1702782","article-title":"Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breast cancer treated with high-dose chemotherapy and stem cell transplantation","volume":"27","author":"Solano","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1704133","article-title":"Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)","volume":"32","author":"Syme","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bmt.1703929","article-title":"Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy","volume":"31","author":"Patriarca","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/sj.bmt.1701247","article-title":"High-dose chemotherapy in patients with breast cancer","volume":"21","author":"Weaver","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bmt.1703878","article-title":"Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4\u20139 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation","volume":"31","author":"Reed","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB29","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.bmt.1704283","article-title":"Occult tumor cell contamination in patients with stage II\/III breast cancer receiving high-dose chemotherapy","volume":"32","author":"Viret","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/bbmt.2002.v8.pm12434948","article-title":"Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer","volume":"8","author":"Pecora","year":"2003","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB31","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/JCO.1998.16.11.3509","article-title":"Occult tumor contamination of hematopoietic stem-cell product does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer","volume":"16","author":"Cooper","year":"1998","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.bmt.1701000","article-title":"High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4\u20139 involved axillary lymph nodes","volume":"20","author":"Bearman","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB33","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1078-0432.CCR-03-0536","article-title":"Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy","volume":"10","author":"Nieto","year":"2004","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1200\/JCO.1998.16.5.1661","article-title":"High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer","volume":"16","author":"Cagnoni","year":"1998","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB35","first-page":"72a","article-title":"Prognostic analysis of the early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy (HDC) with an autologous hematopoietic progenitor cell transplant","volume":"9","author":"Nieto","year":"2003","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB36","first-page":"1731","article-title":"Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease","volume":"5","author":"Nieto","year":"1999","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1200\/JCO.1994.12.1.28","article-title":"Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy","volume":"12","author":"Shpall","year":"1994","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/hyb.1990.9.221","article-title":"Biochemical and histological characterization of antigens preferentially expressed on the surface and cytoplasm of breast carcinoma cells identified by monoclonal antibodies against the human milk fat globule","volume":"9","author":"Peterson","year":"1990","journal-title":"Hybridoma."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB39","first-page":"457","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"JAMA."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2307\/2344317","article-title":"Asymptomatically efficient rank invariant test procedures","volume":"135","author":"Peto","year":"1971","journal-title":"J R Stat Soc A."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB42","first-page":"3425","article-title":"A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem cell transplant","volume":"5","author":"Nieto","year":"1999","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB43","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1200\/JCO.2000.18.10.2070","article-title":"Prognostic value of HER2 overexpression and mutations in p53 in high-risk primary breast cancer treated with high-dose chemotherapy and autologous stem cell transplant","volume":"18","author":"Nieto","year":"2000","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB44","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1200\/JCO.2002.20.3.707","article-title":"Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer","volume":"20","author":"Nieto","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","article-title":"Gene-marking to trace origin of relapse after autologous bone marrow transplantation","volume":"341","author":"Brenner","year":"1993","journal-title":"Lancet."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB46","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1182\/blood.V83.10.3068.3068","article-title":"Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia contribute to relapse after autologous bone marrow transplant in CML","volume":"83","author":"Deisseroth","year":"1994","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB47","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","article-title":"Immunologic purging of bone marrow assessed before autologous bone marrow transplantation for B cell lymphoma","volume":"325","author":"Gribben","year":"1991","journal-title":"N Engl J Med."},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2004.02.004_BIB48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/stem.5530100731","article-title":"Detection and clinical significance of minimal tumor cell contamination of peripheral blood stem cell harvests","volume":"10","author":"Sharp","year":"1992","journal-title":"Int J Cell Cloning."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JCO.1991.9.1.85","article-title":"4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support","volume":"9","author":"Shpall","year":"1991","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB50","first-page":"145","article-title":"Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation","volume":"7","author":"Shpall","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB51","first-page":"4659","article-title":"Elimination of malignant clonogenic breast cancer cells from human bone marrow","volume":"15","author":"Anderson","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB52","first-page":"339a","article-title":"High-dose chemotherapy and immunomagnetically purged peripheral blood progenitor cells and bone marrow for metastatic breast carcinoma","volume":"15","author":"Vredenburgh","year":"1996","journal-title":"Proc Am Soc Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V87.1.1.1","article-title":"CD34","volume":"87","author":"Krause","year":"1996","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB54","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood.V90.11.4313","article-title":"A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy","volume":"90","author":"Shpall","year":"1997","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB55","first-page":"17a","article-title":"High dose chemotherapy and stem cell transplant in breast cancer","volume":"20","author":"Cornetta","year":"2001","journal-title":"Proc Am Soc Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB56","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.bmt.1702415","article-title":"Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer","volume":"25","author":"Yanovich","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB57","first-page":"1035","article-title":"Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy","volume":"5","author":"Mohr","year":"1999","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB58","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/jnci\/85.17.1419","article-title":"Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells","volume":"85","author":"Pantel","year":"1993","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1200\/JCO.2000.18.1.80","article-title":"Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in BM of high-risk breast cancer patients","volume":"18","author":"Braun","year":"2000","journal-title":"J Clin Oncol."},{"issue":"suppl 10","key":"10.1016\/j.bbmt.2004.02.004_BIB60","first-page":"128A","article-title":"Persistence of isolated tumor cells in patients with breast cancer after sequential high-dose therapy with PB stem cell transplantation (PBSC)","volume":"88","author":"Hohaus","year":"1996","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB61","first-page":"1582","article-title":"Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy","volume":"7","author":"Kasimir-Bauer","year":"2001","journal-title":"Clin Cancer Res."},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2004.02.004_BIB62","first-page":"379B","article-title":"Adoptive immunotherapy with the monoclonal antibody (moab) 17\/1A to reduce minimal residual disease in breast cancer patients after high dose chemotherapy","volume":"90","author":"Hempel","year":"1997","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB63","series-title":"Blood Stem Cell Transplantation","first-page":"187","article-title":"CD34+ blood stem cell transplantation","author":"Nieto","year":"1998"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2004.02.004_BIB64","first-page":"300","article-title":"Peripheral T cell levels correlate with outcome in patients undergoing autologous stem cell transplant","volume":"6","author":"Rosinski","year":"2002","journal-title":"Exp Hematol."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bmt.1703236","article-title":"Prolonged survival associated with early lymphocyte recovery after autologous stem cell transplantation for patients with metastatic breast cancer","volume":"28","author":"Porrata","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V94.1.340.413k09_340_347","article-title":"Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone","volume":"94","author":"Franklin","year":"1999","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1182\/blood.V83.3.623.623","article-title":"Release of tumor cells from bone marrow","volume":"83","author":"Shpall","year":"1994","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB68","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood.V83.3.636.636","article-title":"Mobilization of tumor cells and hematopoietic progenitor cells into PB of patients with solid tumors","volume":"83","author":"Brugger","year":"1994","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB69","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1182\/blood.V85.4.1138.bloodjournal8541138","article-title":"Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor","volume":"85","author":"Passos-Coelho","year":"1995","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.02.004_BIB70","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1200\/JCO.1996.14.9.2569","article-title":"Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor","volume":"14","author":"Passos-Coelho","year":"1996","journal-title":"J Clin Oncol."}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:20:54Z","timestamp":1761056454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879104000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1083879104000886"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.02.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}